Kura Oncology, Inc. · NASDAQ:KURA
BVF PARTNERS L P/IL reported a 9.99% stake in Kura Oncology, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
BVF PARTNERS L P/IL reported a 9.99% stake in Kura Oncology, Inc., 8,677,018 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 8,677,018
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 5.10% | 4,416,545 |
| BVF I GP LLC | 5.10% | 4,416,545 |
| BIOTECHNOLOGY VALUE FUND II LP | 4.20% | 3,640,106 |
| BVF II GP LLC | 4.20% | 3,640,106 |
| Biotechnology Value Trading Fund OS LP | 0.50% | 446,606 |
| BVF Partners OS Ltd. | 0.50% | 446,606 |
| BVF GP HOLDINGS LLC | 9.30% | 8,056,651 |
| BVF PARTNERS L P/IL | 9.99% | 8,677,018 |
| BVF INC/IL | 9.99% | 8,677,018 |
| LAMPERT MARK N | 9.99% | 8,677,018 |
Source
Related
- Kura Oncology, Inc.
- Bvf Partners L P
- Kura Oncology, Inc. shareholders
- Schedule 13G/A · Bvf Partners L P · Feb 4, 2025
- Schedule 13G · Bvf Partners L P · Feb 4, 2025
- Form 4 · Ford Kathleen · Sep 29, 2026
- Form 4 · Leoni Mollie · Sep 29, 2026
- Form 4 · Powl Brian T. · Sep 29, 2026
- Form 4 · Bair Teresa Brophy · Sep 29, 2026
- Form 4 · Doyle Thomas James · Sep 29, 2026